Accordingly, DPP4 inhibitors and GLP-1(7-37) receptor agonists (GLP-1RA) have become important drugs for the treatment of type 2 diabetes (Palmer et al, 2016). Here, DPP4 is linked to type 2 diabetes mellitus.